참고문헌
- Chandran A, Watt JP, Santosham M. Haemophilus influenzae vaccine. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed. Philadelphia: Elsevier Health Sciences, 2013:167-82.
- Pittman M. Variation and type specificity in the bacterial species Hemophilus influenzae. J Exp Med 1931;53:471-92. https://doi.org/10.1084/jem.53.4.471
- Kim KH, Lee H, Chung EH, Kang JH, Kim JH, Kim JS, et al. Immunogenicity and safety of two different Haemophilus influenzae type b conjugate vaccines in Korean infants. J Korean Med Sci 2008;23:929-36. https://doi.org/10.3346/jkms.2008.23.6.929
- Kim HW, Kim KH, Kim J, Nahm MH. A high throughput serum bactericidal assay for antibodies to Haemophilus influenzae type b. BMC Infect Dis 2016;16:473. https://doi.org/10.1186/s12879-016-1808-4
- Mackenzie GA, Ikumapayi UN, Scott S, Idoko O, Odutola A, Ndiaye M, et al. Increased disease due to Haemophilus influenzae type b: population-based surveillance in eastern Gambia, 2008-2013. Pediatr Infect Dis J 2015;34:e107-12. https://doi.org/10.1097/INF.0000000000000645
- Idoko OT, Roberts E, Cox M, Jafali J, Njie-Jobe J, Mackenzie G, et al. Antibodies against Haemophilus influenzae type b in The Gambia: investigating the extent of protection across age groups. Vaccine 2014;32:4620-4. https://doi.org/10.1016/j.vaccine.2014.06.078
- McVernon J, Trotter CL, Slack MP, Ramsay ME. Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study. BMJ 2004;329: 655-8. https://doi.org/10.1136/bmj.329.7467.655
- Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis 2007;44:810-6. https://doi.org/10.1086/511861
- Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, et al. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis 2011;17:1645-50. https://doi.org/10.3201/eid1709.101991
- Shuel M, Hoang L, Law DK, Tsang R. Invasive Haemophilus influenzae in British Columbia: non-Hib and nontypeable strains causing disease in children and adults. Int J Infect Dis 2011;15:e167-73. https://doi.org/10.1016/j.ijid.2010.10.005
- Kim KH, Lim SY. Validation of enzyme immunoassay for the quantitative measurement of human IgG antibodies specific for Haemophilus influenzae type b capsular poly saccharide. Korean J Pediatr 2007;50:143-50. https://doi.org/10.3345/kjp.2007.50.2.143
- Peltola H, Kayhty H, Sivonen A, Makela H. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics 1977;60: 730-7.
- Oh SY, Griffiths D, John T, Lee YC, Yu LM, McCarthy N, et al. School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom. J Infect Dis 2008;197:1275-81. https://doi.org/10.1086/586716
- Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100. https://doi.org/10.1093/infdis/147.6.1100
- Nix EB, Hawdon N, Gravelle S, Biman B, Brigden M, Malik S, et al. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era. Clin Vaccine Immunol 2012;19:766-71. https://doi.org/10.1128/CVI.05675-11
- Chalmers C. Necrotising fasciitis complicating Haemophilus influenzae type b epiglottitis in an adult. J Laryngol Otol 2010;124:807-9. https://doi.org/10.1017/S0022215109992076
- Saito T, Matsunaga H, Matsumura Y, Segawa H, Takakura S, Nagao M, et al. Necrotizing fasciitis caused by Haemophilus influenzae type b in an elderly patient. J Clin Microbiol 2009;47:852-4. https://doi.org/10.1128/JCM.01196-08
- Chew CG, Clarkson AR, Faull RJ. Relapsing CAPD peritonitis with rapid peritoneal sclerosis due to Haemophilus influenzae. Nephrol Dial Transplant 1997;12:821-2. https://doi.org/10.1093/ndt/12.4.821
- Neuhaus TJ, Iselin H, Nadal D. Haemophilus influenzae: a cause of peritonitis in peritoneal dialysis. Nephrol Dial Transplant 1996;11:199-200. https://doi.org/10.1093/ndt/11.1.199
- Public Health Agency of Canada. Canadian immunization guide 2006. 7th ed. Ottawa: Public Health Agency of Canada, 2006.
- Collins S, Ramsay M, Campbell H, Slack MP, Ladhani SN. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination? Clin Infect Dis 2013;57:1715-21. https://doi.org/10.1093/cid/cit579
- Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, et al. Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990-2007. Clin Infect Dis 2009;49:85-92. https://doi.org/10.1086/599369
- Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005;41:839-47. https://doi.org/10.1086/432804
- Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI. Comparison of naturally acquired and vaccineinduced antibodies to Haemophilus influenzae type b capsular polysaccharide. Infect Immun 1993;61:5345-50.
- Kim YJ, Hwang JY, Choi SH, Kong E, Kim Y, Park KS, et al. Antibody responses in hematopoietic cell transplantation recipients after vaccination against Haemophilus influenzae type b and Streptococcus pneumoniae. Korean J Pediatr Infect Dis 2014;21:81-95. https://doi.org/10.14776/kjpid.2014.21.2.81
- Lee H, Nahm MH, Burton R, Kim KH. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol 2009;16:376-81. https://doi.org/10.1128/CVI.00344-08
- Song JY, Moseley MA, Burton RL, Nahm MH. Pneumococcal vaccine and opsonic pneumococcal antibody. J Infect Chemother 2013;19:412-25. https://doi.org/10.1007/s10156-013-0601-1
- World Health Organization. Guidelines on clinical evaluation of vaccines: regulatory expectations. Proposed revision of WHO TRS 924, Annex 1 [Internet]. Geneva: World Health Organization; 2004 [cited 2017 Nov 7]. Available from: http://www.who.int/biologicals/BS2287_Clinical_guidelines_final_LINE_NOs_20_July_2016.pdf.
- Cho HK, Park IH, Burton RL, Kim KH. Impact of IgM antibodies on cross-protection against pneumococcal serogroups 6 and 19 after immunization with 7-valent pneumococcal conjugate vaccine in children. J Korean Med Sci 2016;31:950-6. https://doi.org/10.3346/jkms.2016.31.6.950
- Kim KH. Present status and prospects of Haemophilus influenzae type b (Hib) immunization. Korean J Pediatr 2006;49:242-50. https://doi.org/10.3345/kjp.2006.49.3.242
- Shinefield HR, Black S. Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up. Pediatr Infect Dis J 1995;14:978-81. https://doi.org/10.1097/00006454-199511000-00011
- Watt JP, Levine OS, Santosham M. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002. J Pediatr 2003;143(6 Suppl):S163-87.